Abstract
The production of the peptide hormones ACTH, α-MSH, and β-endorphin requires proteolytic processing of POMC which is hypothesized to utilize dual cysteine- and subtilisin-like protease pathways, consisting of the secretory vesicle cathepsin L pathway and the well-known subtilisin-like prohormone convertase (PC) pathway. To gain knowledge of these protease components in human pituitary where POMC-derived peptide hormones are produced, this study investigated the presence of these protease pathway components in human pituitary. With respect to the cathepsin L pathway, human pituitary contained cathepsin L of 27–29 kDa and aminopeptidase B of ~64 kDa, similar to those in secretory vesicles of related neuroendocrine tissues. The serpin inhibitor endopin 2, a selective inhibitor of cathepsin L, was also present. With respect to the PC pathway, human pituitary expresses PC1/3 and PC2 of ~60–65 kDa, which represent active PC1/3 and PC2; peptide hormone production then utilizes carboxypeptidase E (CPE) which is present as a protein of ~55 kDa. Analyses of POMC products in human pituitary showed that they resemble those in mouse pituitary which utilizes cathepsin L and PC2 for POMC processing. These findings suggest that human pituitary may utilize the cathepsin L and prohormone convertase pathways for producing POMC-derived peptide hormones.
Similar content being viewed by others
References
M. Thomas, M. Keramidas, E. Monchaux, J.J. Feige, Microsc. Res. Tech. 61, 247–251 (2003)
H. Krude, A. Gruters, Trends Endocrinol. Metab. 11, 15–22 (2000)
L.K. Heisler, M.A. Cowley, T. Kishi, L.H. Tecott, W. Fan, M.J. Low, J.L. Smart, M. Rubinstein, J.B. Tatro, J.M. Zigman, R.D. Cone, J.K. Elmquist, Ann. N Y Acad. Sci. 994, 169–174 (2003)
P. Kokkoris, F.X. Pi-Sunyer, Endocrinol. Metab. Clin. North Am. 32, 895–914 (2003)
A.T. Slominski, J. Invest. Dermatol. 126, 1934–1936 (2006)
H. Takahashi, Y. Hakamata, Y. Watanabe, R. Kikuno, T. Miyata, S. Numa, Nucleic Acids Res. 11, 6847–6858 (1983)
L.E. Pritchard, A. White, Endocrinology 148, 4201–4207 (2007)
M.G. Castro, E. Morrison, Crit. Rev. Neurobiol. 11, 35–37 (1997)
X. Bertagna, Endocrinol. Metab. Clin. North Am. 23, 467–485 (1994)
S. Yasothornsrikul, W. Aaron, T. Toneff, V. Hook, Biochemistry 38, 7421–7430 (1999)
S. Yasothornsrikul, D. Greenbaum, K.F. Medzihradszky, T. Toneff, R. Bundey, R. Miller, B. Schilling, I. Petermann, J. Dehnert, A. Logvinova, P. Goldsmith, J.M. Neveu, W.S. Lane, B. Gibson, T. Reinheckel, C. Peters, M. Bogyo, V. Hook, Proc. Natl. Acad. Sci. USA 100, 9590–9595 (2003)
S.R. Hwang, C. Garza, C. Mosier, T. Toneff, E. Wunderlich, P. Goldsmith, V. Hook, J. Biol. Chem. 282, 9556–9563 (2007)
S.R. Hwang, A. O’Neill, S. Bark, T. Foulon, V. Hook, J. Neurochem. 100, 1340–1350 (2007)
V. Hook, L. Funkelstein, D. Lu, S. Bark, J. Wegrzyn, S.R. Hwang, Annu. Rev. Pharmacol. Toxicol. 48, 393–423 (2008)
N.G. Seidah, M. Chretien, Brain Res. 848, 45–62 (1999)
A. Zhou, G. Webb, X. Zhu, D.F. Steiner, J. Biol. Chem. 274, 20745–20748 (1999)
L.D. Fricker, Annu. Rev. Physiol. 50, 309–321 (1988)
V.Y. Hook, L.E. Eiden, M.J. Brownstein, Nature 295, 341–342 (1982)
V.Y.H. Hook, E. Mezey, L.D. Fricker, R.M. Pruss, R.E. Siegel, M.J. Brownstein, Proc. Natl. Acad. Sci. USA 82, 4745–4749 (1985)
L. Funkelstein, T. Toneff, C. Mosier, S.R. Hwang, F. Beuschlein, U.D. Lichtenauer, T. Reinheckel, C. Peters, V. Hook, J. Biol. Chem. 283, 35652–35659 (2008)
R. Miller, W. Aaron, T. Toneff, D. Vishnuvardhan, M.C. Beinfeld, V.Y. Hook, J. Neurochem. 86, 556–563 (2003)
V. Laurent, L. Jaubert-Miazza, R. Desjardins, R. Day, I. Lindberg, Endocrinology 145, 519–528 (2004)
R.G. Allen, B. Peng, M.J. Pellegrino, E.D. Miller, D.K. Grandy, J.R. Lundblad, C.L. Washbrun, J.E. Pintar, J. Neurosci. 21, 5864–5870 (2001)
H. Pan, F.Y. Che, B. Png, D.F. Steiner, J.E. Pintar, L.D. Fricker, J. Neurochem. 98, 1763–1777 (2006)
H. Pan, D. Nanno, F.Y. Che, X. Zhu, S.R. Salton, D.F. Steiner, L.D. Fricker, L.A. Devi, Biochemistry 44, 4939–4948 (2005)
X. Zhu, A. Zhou, A. Dey, C. Norrbom, R. Carroll, C. Zhang, V. Laurent, I. Lindberg, R. Ugleholdt, J.J. Holst, D.F. Steiner, Proc. Natl. Acad. Sci. USA 99, 10293–10298 (2002)
S.R. Hwang, B. Steineckert, T. Toneff, R. Bundey, A.V. Logvinova, P. Goldsmith, V.Y. Hook, Biochemistry 41, 10397–10405 (2002)
S.R. Hwang, V. Stoka, V. Turk, V.Y. Hook, Biochemistry 44, 7757–7767 (2005)
A.V. Azaryan, T.J. Krieger, V.Y. Hook, J. Biol. Chem. 270, 8201–8208 (1995)
N.S. Lamango, X. Zhu, I. Lindberg, Arch. Biochem. Biophys. 330, 238–250 (1996)
Y. Zhou, I. Lindberg, J. Biol. Chem. 268, 5615–5623 (1993)
E.M. Peters, D.J. Tobin, N.G. Seidah, K.U. Schallreuter, J. Invest. Dermatol. 114, 430–437 (2000)
D.L. Bennett, E.M. Bailyes, E. Nielsen, P.C. Guest, N.G. Rutherford, S.D. Arden, J.C. Hutton, J. Biol. Chem. 267, 15229–15236 (1992)
H.W. Davidson, J.C. Hutton, Biochem. J. 245, 575–582 (1987)
S. Benjannet, N. Rondeau, R. Day, M. Chretien, N.G. Seidah, Proc. Natl. Acad. Sci. USA 88, 3564–3568 (1991)
I. Takumi, D.F. Steiner, N. Sanno, A. Teramoto, Y. Osamura, Mod. Pathol. 11, 232–238 (1998)
X. Fan, S.J. Olson, M.D. Johnson, J. Histochem. Cytochem. 49, 783–790 (2001)
S.R. Hwang, B. Steineckert, V.Y. Hook, Biochemistry 39, 8944–8952 (2000)
A.V. Azaryan, T.J. Krieger, V.Y.H. Hook, J. Biol. Chem. 270, 8208–8291 (1995)
S.R. Hwang, R. Bundey, T. Toneff, V. Hook, Neuroendocrinology 89, 210–216 (2008)
Acknowledgments
The authors appreciate support of this research by the National Institutes of Health. Assistance for this project by D. Tierney is acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hook, V., Funkelstein, L., Toneff, T. et al. Human pituitary contains dual cathepsin L and prohormone convertase processing pathway components involved in converting POMC into the peptide hormones ACTH, α-MSH, and β-endorphin. Endocr 35, 429–437 (2009). https://doi.org/10.1007/s12020-009-9163-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-009-9163-5